The recent outbreak of Severe Acute Respiratory Syndrome (SARS) is a striking example of a potentially devastating emerging infectious disease. Although the initial SARS outbreak was contained through public health efforts, the epidemiology of respiratory virus infections in humans suggests that re-emergence of this disease is a distinct possibility. Unfortunately, current antiviral therapies did not prove effective in SARS patients. Thus, developing an effective vaccine is likely the best strategy for limiting this disease in the human population. The evidence to date is that SARS is caused by a human coronavirus (SARS-CoV), and the sequence of this virus has been determined. However, as useful as the molecular information may be for understanding the relationship of SARS-CoV to other coronaviruses, it is not sufficient to predict how the virus behaves in vivo and what elements of the virus will be targets for effective vaccination. Studies with respiratory virus infections suggest that disease pathogenesis may result from virus-mediated lysis of infected cells, the host immune response, or both. While limited, early studies with SARS patients reveal low, but constant levels of virus in the serum, during disease progression. This suggests that the immune system is contributing to the pathogenesis of disease. Alternatively, or in addition, the virus may evade the immune system in order to persist. Experimental systems to address SARS-CoV pathogenesis have not been described and very little is known about the immune response to SARS-CoV. In large part, the progress from molecular characterization of human viruses to vaccines is hampered by the lack of suitable small animal models for studies of pathogenesis and immune responses. The long-term goal of this project is to develop a mouse model to provide information on the pathogenesis and immune response to SARS-CoV that will be useful in designing vaccines to protect the population. We will address this long-term goal with the following specific aims:
Aim 1. Characterize the specificity of the anti-SARS-CoV human CD8+ T cell response with HLA-A*201-transgenic mice and generate SARS-CoV protein-specific monoclonal antibodies.
Aim 2. Determine if SARS-CoV proteins modulate adaptive immunity in the context of infection.
Aim 3. Determine if SARS-CoV proteins modulate DC and NK immunity in the context of infection.
Aim 4. Determine if SARS-CoV proteins modulate lung pathology in the context of infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI060699-05
Application #
7687947
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2008-08-01
Budget End
2009-06-30
Support Year
5
Fiscal Year
2008
Total Cost
$333,807
Indirect Cost
Name
University of Iowa
Department
Type
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Canton, Javier; Fehr, Anthony R; Fernandez-Delgado, Raúl et al. (2018) MERS-CoV 4b protein interferes with the NF-?B-dependent innate immune response during infection. PLoS Pathog 14:e1006838
Fehr, Anthony R; Jankevicius, Gytis; Ahel, Ivan et al. (2018) Viral Macrodomains: Unique Mediators of Viral Replication and Pathogenesis. Trends Microbiol 26:598-610
Alshukairi, Abeer N; Zheng, Jian; Zhao, Jingxian et al. (2018) High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia. MBio 9:
Sodhi, Chhinder P; Wohlford-Lenane, Christine; Yamaguchi, Yukihiro et al. (2018) Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration. Am J Physiol Lung Cell Mol Physiol 314:L17-L31
Castaño-Rodriguez, Carlos; Honrubia, Jose M; Gutiérrez-Álvarez, Javier et al. (2018) Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis. MBio 9:
Zheng, Jian; Perlman, Stanley (2018) Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host. Curr Opin Virol 28:43-52
Chu, Daniel K W; Hui, Kenrie P Y; Perera, Ranawaka A P M et al. (2018) MERS coronaviruses from camels in Africa exhibit region-dependent genetic diversity. Proc Natl Acad Sci U S A 115:3144-3149
Galasiti Kankanamalage, Anushka C; Kim, Yunjeong; Damalanka, Vishnu C et al. (2018) Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element. Eur J Med Chem 150:334-346
Grunewald, Matthew E; Fehr, Anthony R; Athmer, Jeremiah et al. (2018) The coronavirus nucleocapsid protein is ADP-ribosylated. Virology 517:62-68
Wang, Yanqun; Sun, Jing; Channappanavar, Rudragouda et al. (2017) Simultaneous Intranasal/Intravascular Antibody Labeling of CD4+ T Cells in Mouse Lungs. Bio Protoc 7:

Showing the most recent 10 out of 111 publications